| Unknown | TPIV100 and Sargramostim for the Treatment of HER2 Positive, Stage II-III Breast Cancer in Patients With Resid NCT04197687 | Academic and Community Cancer Research United | Phase 2 |
| Terminated | Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Patho NCT03872388 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence NCT04054557 | Thomas Jefferson University | N/A |
| Completed | SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer NCT03411070 | Jonsson Comprehensive Cancer Center | EARLY_Phase 1 |
| Completed | Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors NCT03407716 | Mayo Clinic | EARLY_Phase 1 |
| Active Not Recruiting | Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery NCT03317405 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and N NCT03094052 | University of California, San Francisco | Phase 2 |
| Completed | The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer NCT03454529 | Michael Simon | Phase 2 |
| Completed | Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery NCT03324802 | Mayo Clinic | Phase 3 |
| Completed | Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors NCT03319342 | Jonsson Comprehensive Cancer Center | N/A |
| Completed | Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery NCT03038152 | M.D. Anderson Cancer Center | Phase 4 |
| Active Not Recruiting | Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Tr NCT03012100 | Academic and Community Cancer Research United | Phase 2 |
| Suspended | Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer NCT03077841 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Active Not Recruiting | Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer NCT02912312 | M.D. Anderson Cancer Center | Phase 2 |
| Recruiting | Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuva NCT02945579 | M.D. Anderson Cancer Center | N/A |
| Completed | Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen P NCT02598557 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC NCT02593175 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Tr NCT02689427 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment NCT02754752 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Cyclophosphamide, Paclitaxel, and Trastuzumab in Treating Stage I-II HER2/Neu Positive Breast Cancer After Sur NCT02654119 | University of Nebraska | Phase 2 |
| Active Not Recruiting | Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer NCT02276443 | M.D. Anderson Cancer Center | N/A |
| Completed | Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer NCT03568526 | Ohio State University Comprehensive Cancer Center | N/A |
| Completed | Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients NCT02003209 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | The Role of Lifestyle Factors in Breast Cancer-Related Outcomes NCT02079662 | M.D. Anderson Cancer Center | N/A |
| Completed | Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer NCT01275677 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carci NCT01266642 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer NCT01245712 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Trea NCT00861705 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Ca NCT00770809 | National Cancer Institute (NCI) | Phase 3 |
| Active Not Recruiting | Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node NCT00310180 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With NCT00005970 | National Cancer Institute (NCI) | Phase 3 |